Circulating Tumor Cells Market - Global Outlook and Forecast 2021-2027

January 2021 | 106 pages | ID: C37D0A62E7D9EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Circulating Tumor Cells in Global, including the following market information:
Global Circulating Tumor Cells Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Circulating Tumor Cells market was valued at 1354.2 million in 2020 and is projected to reach US$ 2763.7 million by 2027, at a CAGR of 19.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Circulating Tumor Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Circulating Tumor Cells Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Circulating Tumor Cells Market Segment Percentages, By Type, 2020 (%)

• CTC Enrichment
• CTC Detection
• CTC Analysis

China Circulating Tumor Cells Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Circulating Tumor Cells Market Segment Percentages, By Application, 2020 (%)

• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Lung Cancer
• Others

Global Circulating Tumor Cells Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Circulating Tumor Cells Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Circulating Tumor Cells Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Circulating Tumor Cells Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:

• Menarini-Silicon Biosystems
• Qiagen (Adnagen)
• Advanced Cell Diagnostics
• ApoCell
• Epic Sciences
• Greiner Bio-one GmbH
• Cynvenio
• SurExamBio-Tech
• Fluxion Biosciences
• Ikonisys
• Hangzhou Watson Biotech
• Biocept
• CytoTrack
• Guangzhou Wondfo Biotech
• Celsee
• Clearbridge Biomedics
• ANGLE plc

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Circulating Tumor Cells Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Circulating Tumor Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CIRCULATING TUMOR CELLS OVERALL MARKET SIZE

2.1 Global Circulating Tumor Cells Market Size: 2021 VS 2027
2.2 Global Circulating Tumor Cells Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Circulating Tumor Cells Players in Global Market
3.2 Top Global Circulating Tumor Cells Companies Ranked by Revenue
3.3 Global Circulating Tumor Cells Revenue by Companies
3.4 Top 3 and Top 5 Circulating Tumor Cells Companies in Global Market, by Revenue in 2020
3.5 Global Companies Circulating Tumor Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Circulating Tumor Cells Players in Global Market
  3.6.1 List of Global Tier 1 Circulating Tumor Cells Companies
  3.6.2 List of Global Tier 2 and Tier 3 Circulating Tumor Cells Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Circulating Tumor Cells Market Size Markets, 2021 & 2027
  4.1.2 CTC Enrichment
  4.1.3 CTC Detection
  4.1.4 CTC Analysis
4.2 By Type - Global Circulating Tumor Cells Revenue & Forecasts
  4.2.1 By Type - Global Circulating Tumor Cells Revenue, 2016-2021
  4.2.2 By Type - Global Circulating Tumor Cells Revenue, 2022-2027
  4.2.3 By Type - Global Circulating Tumor Cells Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Circulating Tumor Cells Market Size, 2021 & 2027
  5.1.2 Breast Cancer
  5.1.3 Prostate Cancer
  5.1.4 Colorectal Cancer
  5.1.5 Lung Cancer
  5.1.6 Others
5.2 By Application - Global Circulating Tumor Cells Revenue & Forecasts
  5.2.1 By Application - Global Circulating Tumor Cells Revenue, 2016-2021
  5.2.2 By Application - Global Circulating Tumor Cells Revenue, 2022-2027
  5.2.3 By Application - Global Circulating Tumor Cells Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Circulating Tumor Cells Market Size, 2021 & 2027
6.2 By Region - Global Circulating Tumor Cells Revenue & Forecasts
  6.2.1 By Region - Global Circulating Tumor Cells Revenue, 2016-2021
  6.2.2 By Region - Global Circulating Tumor Cells Revenue, 2022-2027
  6.2.3 By Region - Global Circulating Tumor Cells Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Circulating Tumor Cells Revenue, 2016-2027
  6.3.2 US Circulating Tumor Cells Market Size, 2016-2027
  6.3.3 Canada Circulating Tumor Cells Market Size, 2016-2027
  6.3.4 Mexico Circulating Tumor Cells Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Circulating Tumor Cells Revenue, 2016-2027
  6.4.2 Germany Circulating Tumor Cells Market Size, 2016-2027
  6.4.3 France Circulating Tumor Cells Market Size, 2016-2027
  6.4.4 U.K. Circulating Tumor Cells Market Size, 2016-2027
  6.4.5 Italy Circulating Tumor Cells Market Size, 2016-2027
  6.4.6 Russia Circulating Tumor Cells Market Size, 2016-2027
  6.4.7 Nordic Countries Circulating Tumor Cells Market Size, 2016-2027
  6.4.8 Benelux Circulating Tumor Cells Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Circulating Tumor Cells Revenue, 2016-2027
  6.5.2 China Circulating Tumor Cells Market Size, 2016-2027
  6.5.3 Japan Circulating Tumor Cells Market Size, 2016-2027
  6.5.4 South Korea Circulating Tumor Cells Market Size, 2016-2027
  6.5.5 Southeast Asia Circulating Tumor Cells Market Size, 2016-2027
  6.5.6 India Circulating Tumor Cells Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Circulating Tumor Cells Revenue, 2016-2027
  6.6.2 Brazil Circulating Tumor Cells Market Size, 2016-2027
  6.6.3 Argentina Circulating Tumor Cells Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Circulating Tumor Cells Revenue, 2016-2027
  6.7.2 Turkey Circulating Tumor Cells Market Size, 2016-2027
  6.7.3 Israel Circulating Tumor Cells Market Size, 2016-2027
  6.7.4 Saudi Arabia Circulating Tumor Cells Market Size, 2016-2027
  6.7.5 UAE Circulating Tumor Cells Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Menarini-Silicon Biosystems
  7.1.1 Menarini-Silicon Biosystems Corporate Summary
  7.1.2 Menarini-Silicon Biosystems Business Overview
  7.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Major Product Offerings
  7.1.4 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue in Global (2016-2021)
  7.1.5 Menarini-Silicon Biosystems Key News
7.2 Qiagen (Adnagen)
  7.2.1 Qiagen (Adnagen) Corporate Summary
  7.2.2 Qiagen (Adnagen) Business Overview
  7.2.3 Qiagen (Adnagen) Circulating Tumor Cells Major Product Offerings
  7.2.4 Qiagen (Adnagen) Circulating Tumor Cells Revenue in Global (2016-2021)
  7.2.5 Qiagen (Adnagen) Key News
7.3 Advanced Cell Diagnostics
  7.3.1 Advanced Cell Diagnostics Corporate Summary
  7.3.2 Advanced Cell Diagnostics Business Overview
  7.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Major Product Offerings
  7.3.4 Advanced Cell Diagnostics Circulating Tumor Cells Revenue in Global (2016-2021)
  7.3.5 Advanced Cell Diagnostics Key News
7.4 ApoCell
  7.4.1 ApoCell Corporate Summary
  7.4.2 ApoCell Business Overview
  7.4.3 ApoCell Circulating Tumor Cells Major Product Offerings
  7.4.4 ApoCell Circulating Tumor Cells Revenue in Global (2016-2021)
  7.4.5 ApoCell Key News
7.5 Epic Sciences
  7.5.1 Epic Sciences Corporate Summary
  7.5.2 Epic Sciences Business Overview
  7.5.3 Epic Sciences Circulating Tumor Cells Major Product Offerings
  7.5.4 Epic Sciences Circulating Tumor Cells Revenue in Global (2016-2021)
  7.5.5 Epic Sciences Key News
7.6 Greiner Bio-one GmbH
  7.6.1 Greiner Bio-one GmbH Corporate Summary
  7.6.2 Greiner Bio-one GmbH Business Overview
  7.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Major Product Offerings
  7.6.4 Greiner Bio-one GmbH Circulating Tumor Cells Revenue in Global (2016-2021)
  7.6.5 Greiner Bio-one GmbH Key News
7.7 Cynvenio
  7.7.1 Cynvenio Corporate Summary
  7.7.2 Cynvenio Business Overview
  7.7.3 Cynvenio Circulating Tumor Cells Major Product Offerings
  7.4.4 Cynvenio Circulating Tumor Cells Revenue in Global (2016-2021)
  7.7.5 Cynvenio Key News
7.8 SurExamBio-Tech
  7.8.1 SurExamBio-Tech Corporate Summary
  7.8.2 SurExamBio-Tech Business Overview
  7.8.3 SurExamBio-Tech Circulating Tumor Cells Major Product Offerings
  7.8.4 SurExamBio-Tech Circulating Tumor Cells Revenue in Global (2016-2021)
  7.8.5 SurExamBio-Tech Key News
7.9 Fluxion Biosciences
  7.9.1 Fluxion Biosciences Corporate Summary
  7.9.2 Fluxion Biosciences Business Overview
  7.9.3 Fluxion Biosciences Circulating Tumor Cells Major Product Offerings
  7.9.4 Fluxion Biosciences Circulating Tumor Cells Revenue in Global (2016-2021)
  7.9.5 Fluxion Biosciences Key News
7.10 Ikonisys
  7.10.1 Ikonisys Corporate Summary
  7.10.2 Ikonisys Business Overview
  7.10.3 Ikonisys Circulating Tumor Cells Major Product Offerings
  7.10.4 Ikonisys Circulating Tumor Cells Revenue in Global (2016-2021)
  7.10.5 Ikonisys Key News
7.11 Hangzhou Watson Biotech
  7.11.1 Hangzhou Watson Biotech Corporate Summary
  7.11.2 Hangzhou Watson Biotech Business Overview
  7.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Major Product Offerings
  7.11.4 Hangzhou Watson Biotech Circulating Tumor Cells Revenue in Global (2016-2021)
  7.11.5 Hangzhou Watson Biotech Key News
7.12 Biocept
  7.12.1 Biocept Corporate Summary
  7.12.2 Biocept Business Overview
  7.12.3 Biocept Circulating Tumor Cells Major Product Offerings
  7.12.4 Biocept Circulating Tumor Cells Revenue in Global (2016-2021)
  7.12.5 Biocept Key News
7.13 CytoTrack
  7.13.1 CytoTrack Corporate Summary
  7.13.2 CytoTrack Business Overview
  7.13.3 CytoTrack Circulating Tumor Cells Major Product Offerings
  7.13.4 CytoTrack Circulating Tumor Cells Revenue in Global (2016-2021)
  7.13.5 CytoTrack Key News
7.14 Guangzhou Wondfo Biotech
  7.14.1 Guangzhou Wondfo Biotech Corporate Summary
  7.14.2 Guangzhou Wondfo Biotech Business Overview
  7.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Major Product Offerings
  7.14.4 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue in Global (2016-2021)
  7.14.5 Guangzhou Wondfo Biotech Key News
7.15 Celsee
  7.15.1 Celsee Corporate Summary
  7.15.2 Celsee Business Overview
  7.15.3 Celsee Circulating Tumor Cells Major Product Offerings
  7.15.4 Celsee Circulating Tumor Cells Revenue in Global (2016-2021)
  7.15.5 Celsee Key News
7.16 Clearbridge Biomedics
  7.16.1 Clearbridge Biomedics Corporate Summary
  7.16.2 Clearbridge Biomedics Business Overview
  7.16.3 Clearbridge Biomedics Circulating Tumor Cells Major Product Offerings
  7.16.4 Clearbridge Biomedics Circulating Tumor Cells Revenue in Global (2016-2021)
  7.16.5 Clearbridge Biomedics Key News
7.17 ANGLE plc
  7.17.1 ANGLE plc Corporate Summary
  7.17.2 ANGLE plc Business Overview
  7.17.3 ANGLE plc Circulating Tumor Cells Major Product Offerings
  7.17.4 ANGLE plc Circulating Tumor Cells Revenue in Global (2016-2021)
  7.17.5 ANGLE plc Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Circulating Tumor Cells Market Opportunities & Trends in Global Market
Table 2. Circulating Tumor Cells Market Drivers in Global Market
Table 3. Circulating Tumor Cells Market Restraints in Global Market
Table 4. Key Players of Circulating Tumor Cells in Global Market
Table 5. Top Circulating Tumor Cells Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Circulating Tumor Cells Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Circulating Tumor Cells Revenue Share by Companies, 2016-2021
Table 8. Global Companies Circulating Tumor Cells Product Type
Table 9. List of Global Tier 1 Circulating Tumor Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Circulating Tumor Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Circulating Tumor Cells Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Circulating Tumor Cells Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Circulating Tumor Cells Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Circulating Tumor Cells Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Circulating Tumor Cells Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Circulating Tumor Cells Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Circulating Tumor Cells Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Circulating Tumor Cells Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Circulating Tumor Cells Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Circulating Tumor Cells Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Circulating Tumor Cells Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Circulating Tumor Cells Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Circulating Tumor Cells Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Circulating Tumor Cells Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Circulating Tumor Cells Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Circulating Tumor Cells Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Circulating Tumor Cells Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Circulating Tumor Cells Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Circulating Tumor Cells Revenue, (US$, Mn), 2022-2027
Table 30. Menarini-Silicon Biosystems Corporate Summary
Table 31. Menarini-Silicon Biosystems Circulating Tumor Cells Product Offerings
Table 32. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 33. Qiagen (Adnagen) Corporate Summary
Table 34. Qiagen (Adnagen) Circulating Tumor Cells Product Offerings
Table 35. Qiagen (Adnagen) Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 36. Advanced Cell Diagnostics Corporate Summary
Table 37. Advanced Cell Diagnostics Circulating Tumor Cells Product Offerings
Table 38. Advanced Cell Diagnostics Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 39. ApoCell Corporate Summary
Table 40. ApoCell Circulating Tumor Cells Product Offerings
Table 41. ApoCell Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 42. Epic Sciences Corporate Summary
Table 43. Epic Sciences Circulating Tumor Cells Product Offerings
Table 44. Epic Sciences Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 45. Greiner Bio-one GmbH Corporate Summary
Table 46. Greiner Bio-one GmbH Circulating Tumor Cells Product Offerings
Table 47. Greiner Bio-one GmbH Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 48. Cynvenio Corporate Summary
Table 49. Cynvenio Circulating Tumor Cells Product Offerings
Table 50. Cynvenio Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 51. SurExamBio-Tech Corporate Summary
Table 52. SurExamBio-Tech Circulating Tumor Cells Product Offerings
Table 53. SurExamBio-Tech Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 54. Fluxion Biosciences Corporate Summary
Table 55. Fluxion Biosciences Circulating Tumor Cells Product Offerings
Table 56. Fluxion Biosciences Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 57. Ikonisys Corporate Summary
Table 58. Ikonisys Circulating Tumor Cells Product Offerings
Table 59. Ikonisys Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 60. Hangzhou Watson Biotech Corporate Summary
Table 61. Hangzhou Watson Biotech Circulating Tumor Cells Product Offerings
Table 62. Hangzhou Watson Biotech Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 63. Biocept Corporate Summary
Table 64. Biocept Circulating Tumor Cells Product Offerings
Table 65. Biocept Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 66. CytoTrack Corporate Summary
Table 67. CytoTrack Circulating Tumor Cells Product Offerings
Table 68. CytoTrack Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 69. Guangzhou Wondfo Biotech Corporate Summary
Table 70. Guangzhou Wondfo Biotech Circulating Tumor Cells Product Offerings
Table 71. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 72. Celsee Corporate Summary
Table 73. Celsee Circulating Tumor Cells Product Offerings
Table 74. Celsee Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 75. Clearbridge Biomedics Corporate Summary
Table 76. Clearbridge Biomedics Circulating Tumor Cells Product Offerings
Table 77. Clearbridge Biomedics Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)
Table 78. ANGLE plc Corporate Summary
Table 79. ANGLE plc Circulating Tumor Cells Product Offerings
Table 80. ANGLE plc Circulating Tumor Cells Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Circulating Tumor Cells Segment by Type
Figure 2. Circulating Tumor Cells Segment by Application
Figure 3. Global Circulating Tumor Cells Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Circulating Tumor Cells Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Circulating Tumor Cells Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Circulating Tumor Cells Revenue in 2020
Figure 8. By Type - Global Circulating Tumor Cells Revenue Market Share, 2016-2027
Figure 9. By Application - Global Circulating Tumor Cells Revenue Market Share, 2016-2027
Figure 10. By Region - Global Circulating Tumor Cells Revenue Market Share, 2016-2027
Figure 11. By Country - North America Circulating Tumor Cells Revenue Market Share, 2016-2027
Figure 12. US Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Circulating Tumor Cells Revenue Market Share, 2016-2027
Figure 16. Germany Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 17. France Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Circulating Tumor Cells Revenue Market Share, 2016-2027
Figure 24. China Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 28. India Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Circulating Tumor Cells Revenue Market Share, 2016-2027
Figure 30. Brazil Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Circulating Tumor Cells Revenue Market Share, 2016-2027
Figure 33. Turkey Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Circulating Tumor Cells Revenue, (US$, Mn), 2016-2027
Figure 37. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Qiagen (Adnagen) Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Advanced Cell Diagnostics Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. ApoCell Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Epic Sciences Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Greiner Bio-one GmbH Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Cynvenio Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. SurExamBio-Tech Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Fluxion Biosciences Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Ikonisys Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Hangzhou Watson Biotech Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Biocept Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. CytoTrack Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Celsee Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Clearbridge Biomedics Circulating Tumor Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)